Dr. Priya M. Rajendran, MD

Dr. Rajendran practices at Menlo Medical Clinic in Menlo Park, California.

Dr. Rajendran's NPI, 1043447972, was assigned on June 18, 2009. Dr. Rajendran graduated from UCSF School of Medicine in 2006. Dr. Rajendran holds California license A102452.

Dr. Rajendran's primary practice is Menlo Medical Clinic, at 321 Middlefield Rd, Menlo Park, CA 94025 in San Mateo County. The practice phone is (650) 498-6500.

Dr. Rajendran's primary practice is Menlo Medical Clinic in Menlo Park, California. Dr. Rajendran is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Medicine Partners. Dmand AI also links Dr. Rajendran to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rajendran practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Rajendran's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Rajendran is board certified in dermatology by the American Board of Dermatology. Dr. Rajendran is licensed in California.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, itchy rashes, rash, skin cyst and skin discoloration among the conditions Dr. Rajendran treats.

CMS data shows 1,423 Medicare services from Dr. Rajendran across 10 procedure codes in 2024, for 178 Medicare patients. Medicare paid $85,131 for them. Every service was in an office.

CMS counts 178 Medicare patients who saw Dr. Rajendran in 2024. The largest group is 65 to 74, with 81 patients. 74% of them have high cholesterol, and 53% have high blood pressure. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rajendran's median patient age at 63, with 53% women.

In 2024, Dr. Rajendran wrote 194 Medicare Part D claims for 115 patients. 96% of them were for generic drugs. CMS names the drug for 155 of them, across 8 drugs with 11 or more claims each, at $3,329 in total drug cost. In 2023, CMS named 114 claims across 4 drugs.

Dr. Rajendran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rajendran as offering telehealth. CMS counts 510 procedures of removal of skin lesions by Dr. Rajendran, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Rajendran, published from 2007 to 2013. 2009 was the busiest year, with 3. The most frequent topics are India, Diarrhea and Feces. Dr. Rajendran has published most often in Arch Dermatol. Dr. Rajendran's most frequent co-authors are Hobart W. Harris, MD, Lori Rachel Holtz, MD and David Matthew Young, PhD.

CMS Open Payments shows 8 general payments to Dr. Rajendran from 6 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Valeant Pharmaceuticals International paid the most, $123.

Dmand AI lists 1 award for Dr. Rajendran.

Dr. Rajendran graduated from UCSF School of Medicine in 2006. Dr. Rajendran is a member of AAD.

Dr. Rajendran is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.